Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study
Open Access
- 2 November 2016
- journal article
- research article
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 24 (1) , 49-57
Abstract
Background In the present study, we conducted a multicenter nationwide survey to investigate the effects of preoperative fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) on the prediction of hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT). Methods From 16 Japanese LT centers, data were collected on 182 recipients with HCC who underwent living donor liver transplantation (LDLT) between February 2005 and November 2013. PET‐positive status was defined as increased uptake of FDG in the tumor compared to the surrounding non‐tumor liver tissue. The median follow‐up after LDLT was 54.5 months (range 1–125 months). Results Postoperative HCC recurrence occurred in 23 patients. Multivariate analysis revealed that exceeding the Milan criteria (MC), alpha‐fetoprotein (AFP) level ≥115 ng/ml, and PET‐positive status were significant and independent risk factors for recurrence. In the over‐MC group, a subgroup of patients with AFP level n = 22) had a significantly lower 5‐year recurrence rate than the other patients (n = 27, 19% vs. 53%, P = 0.019). Conclusions These results suggest that preoperative FDG‐PET status offers additional information on HCC recurrence risk after LT. Over‐MC patients with PET‐negative status and lower AFP level may achieve successful outcome comparable to that of within‐MC patients.Keywords
This publication has 32 references indexed in Scilit:
- An Early Regional Experience with Expansion of Milan Criteria for Liver Transplant RecipientsAmerican Journal of Transplantation, 2010
- Liver transplantation for hepatocellular carcinoma: the Hong Kong experienceJournal of Hepato-Biliary-Pancreatic Sciences, 2009
- Liver transplantation for hepatocellular carcinoma: the Kyoto experienceJournal of Hepato-Biliary-Pancreatic Sciences, 2009
- Liver Transplantation for Hepatocellular CarcinomaAnnals of Surgical Oncology, 2008
- Expansion of Selection Criteria for Patients with Hepatocellular Carcinoma in Living Donor Liver TransplantationLiver Transplantation, 2007
- Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative ImagingAmerican Journal of Transplantation, 2007
- Living Donor Liver Transplantation for Hepatocellular Carcinoma: Tokyo University SeriesDigestive Diseases, 2007
- Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be ExpandedAnnals of Surgery, 2007
- Extended Indication for Living Donor Liver Transplantation in Patients With Hepatocellular CarcinomaTransplantation, 2007
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996